UCLA researchers for the first time measure the cost of care for a common prostate condition
3/13/2015
How much does health care really cost?UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using...
Urging HPV vaccine for boys could protect more people at same price
3/13/2015
A Duke University study proposes a strategy to better use limited public health care dollars for protecting more people from a sexually transmitted infection called human papillomavirus (HPV) and the...
Deadly to cancer cells only
3/13/2015
A molecular cause for selective effectiveness of parvovirus therapy discoveredParvoviruses are a class of viruses that normally infect rodents; in humans, they do not cause any disease symptoms.
An injectable UW polymer could keep soldiers, trauma patients from bleeding to death
3/13/2015
Most military battlefield casualties die before reaching a surgical hospital. Of those soldiers who might potentially survive, most die from uncontrolled bleeding.
Bioelectricity plays key role in brain development and repair
3/13/2015
More than on/off switch, electric signals tell cells where and how to growResearch reported by Tufts University biologists shows for the first time that bioelectrical signals among cells...
Regenstrief study finds natural language processing accurately tracks colonoscopy quality
3/13/2015
An accurate system for tracking the quality of colonoscopies and determining the appropriate intervals between these procedures could contribute to both better health outcomes and lower costs.
Naproxen plus acid-blocking drug shows promise in preventing bladder cancer
3/13/2015
Combining naproxen and omeprazole, which reduces GI side effects in humans, prevented bladder cancer in animal modelThe anti-inflammatory class of drugs NSAIDs have shown great promise in...
New clues about the risk of cancer from low-dose radiation
3/13/2015
Berkeley Lab research could lead to ways to ID people particularly susceptible to cancerScientists from the U.S.
DeuteRx's novel approach to chiral switching for racemic drugs
3/13/2015
Results with thalidomide analogs published in the Proceedings of the National Academy of ScienceDeuteRx, LLC, is a research and development-focused biotechnology company dedicated to improving...
Engineered cells could help tackle the third most common cancer in Chinese males
3/13/2015
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.